3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Lymphoma, Follicular
6
Leukemia, Lymphocytic, Chronic, B-Cell
4
Lymphoma, Non-Hodgkin
3
Lymphoma, Mantle-Cell
3
Lymphoma
3
Lymphoma, Large B-Cell, Diffuse
2
Neoplasms
1
Lymphoma, T-Cell
1
Lymphoma, B-Cell
1
Interventions
pembrolizumab
15
Cisplatin
7
Cetuximab
5
Surveys and Questionnaires
4
dostarlimab
3
Carboplatin
3
fludarabine
2
abemaciclib
2
Standard of Care
2
Radiotherapy, Intensity-Modulated
2
Paclitaxel
2
Nivolumab
2
Interviews as Topic
2
Fulvestrant
2
Docetaxel
2
Cyclophosphamide
2
Blood Specimen Collection
2
130-nm albumin-bound paclitaxel
2
ulixertinib
1
trastuzumab deruxtecan
1
toripalimab
1
tislelizumab
1
tipifarnib
1
ribociclib
1
repotrectinib
1
patritumab deruxtecan
1
palbociclib
1
osimertinib
1
olaparib
1
niraparib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Head and Neck Neoplasms
×
Bendamustine Hydrochloride
×
30 days
×
Clear all
No trials found.